Ot - Role of Ot in Pulmonary Rehab
Ot - Role of Ot in Pulmonary Rehab
Ot - Role of Ot in Pulmonary Rehab
This course is offered for 0.3 CEUs (Intermediate level; Category 2 – Occupational Therapy
Process: Evaluation; Category 2 – Occupational Therapy Process: Intervention; Category 2 –
Occupational Therapy Process: Outcomes).
The assignment of AOTA CEUs does not imply endorsement of specific course content, products,
or clinical procedures by AOTA.
Course Abstract
This course provides an overview of Occupational Therapy’s role in pulmonary rehabilitation,
with attention to diagnoses, terminology and procedures, and process. It concludes with case
studies.
Target audience: Occupational Therapists, Occupational Therapy Assistants (no prerequisites).
NOTE: Links provided within the course material are for informational purposes only. No endorsement of
processes or products is intended or implied.
Learning Objectives
By the end of this course, learners will be able to:
❏ Differentiate between primary pulmonary diagnoses
❏ Identify terminology and procedures pertaining to pulmonary rehabilitation
❏ Recognize roles of occupational therapy in pulmonary rehabilitation
❏ Recall elements of three pulmonary rehabilitation-focused case studies
Pathophysiology: Description:
The infecting organism can be inhaled, spread directly Rather than referring to one specific disease, interstitial
from another site, or carried via the bloodstream, and lung disease is a group of disorders that share a similar
impacts the lower respiratory tract. Once colonized, clinical profile. The chief characteristic is scarring of
infection may develop. Viral pneumonia creates the pulmonary interstitium, which includes the walls
interstitial inflammation, first affecting the bronchial of the alveoli and the microscopic spaces around the
mucous glands before spreading to the alveoli, which blood vessels. Scarring causes progressive lung stiffness
fill with fluid and purulent material (pus). Bacterial impacting the ability to breathe.21 Disorders associated
pneumonia triggers an inflammation of the alveoli with ILD may be of known or unknown etiology.22
causing low ventilation that congests the capillaries. It has not been possible to accurately estimate the
In turn, alveoli fill with fluid and purulent material. prevalence of ILD given the diverse number of
In aspiration pneumonia, particles of inhaled associated diseases and variation in etiology.23
foreign material may obstruct airways and trigger an ILD associated with exposure to toxic agents:
inflammatory response. Regardless of pathway, gas The most common toxic agents associated with
exchange is restricted making breathing difficult.16 occupational exposure include asbestos, commonly
Clinical Picture: found among electricians, auto mechanics, and pipe
fitters; silica, commonly attributed to mining and
While the clinical picture may vary depending foundry work; and coal dust, associated with mining
upon the type of pneumonia, the most common and granite workers. Additionally, prolonged exposure
symptoms include dyspnea, a cough, fever, shaking to therapeutic radiation in the management of cancer
chills, fatigue, substernal discomfort, and myalgia. is also a known contributor to the development of
While the prognosis is good for those with healthy acute inflammation that can cause lung scarring
lungs, immediate medical attention is indicated when over time. Individuals exposed to birds or molds
there is a persistent fever above 102 F, a lasting cough may also develop inflammation and hypersensitivity
with excess sputum, or chest pain.16 It is particularly pneumonitis. 22,23
important for those in high risk groups to seek
immediate medical attention. For example, pneumonia ILD associated with systemic disease: ILD is a
can quickly escalate to life-threatening status in those common complication of a number of connective
individuals with chronic heart failure, underlying lung tissue diseases, including rheumatoid arthritis,
disease, or suppressed immune systems, such as those scleroderma, and systemic lupus erythematosus.
receiving chemotherapy.3 Sarcoidosis, a multi-system inflammatory disease, is
the most common ILD in the United States affecting
Diagnosis is made via a chest X-ray to confirm more women than men and individuals over the age of
infiltrates, a sputum specimen, blood cultures, and 20.22,24
a white blood count to differentiate the type of
organism present and whether the infection is viral or ILD of unknown etiology: Despite evaluation
bacterial in origin. Pulse oximetry may also indicate efforts to determine origin, underlying systemic
oxygen saturation levels in the blood.19 Treatment disease association, or genetic predisposition, many
for pneumonia is primarily focused on managing individuals with ILD belong in the idiopathic
the infection and preventing complications. In interstitial pneumonia (IIP) category. The most
many cases, individuals with community-acquired common IIP is idiopathic pulmonary fibrosis, a
pneumonia (CAP) may be treated at home, although crippling disorder with minimal treatment options
symptoms may persist for up to a month. Typically, most commonly affecting individuals over the age of
treatment includes antibiotics for bacterial pneumonia 60. It has a poor prognosis due to rapid progressive
or an anti-viral medication for viral pneumonia, scarring.22,25
antipyretics to reduce fever, rest, and increased fluid
Pathophysiology:
intake. In more serious cases, hospitalization may be
indicated and the individual may receive supplemental The pulmonary interstitium is a collection of tissue
oxygen, intravenous (IV) fluids, and breathing within the lungs that includes the space between
13. M
acNee, W. (2006). ABC of chronic obstructive 26. Raghu, G., & Brown, K. K. (2004). Interstitial
pulmonary disease: pathology, pathogenesis, and lung disease: clinical evaluation and keys to an
pathophysiology. BMJ: British Medical Journal, accurate diagnosis. Clinics in chest medicine, 25(3),
332(7551), 1202. 409-419.
14. M
ayo Clinic (n.d.). Diseases and conditions: COPD 27. Mayo Clinic (n.d.). Diseases and conditions:
tests and diagnosis. Retrieved from http://www. Interstitial lung disease treatment and drugs.
mayoclinic.org/diseases-conditions/copd/basics/ Retrieved from http://www.mayoclinic.org/
tests-diagnosis/con-20032017 diseases-conditions/interstitial-lung-disease/
basics/treatment/con-20024481
15. M
ayo Clinic (n.d.). Diseases and conditions: COPD
treatments and drugs. Retrieved from http://www. 28. American Lung Association (n.d.). Lung and health
mayoclinic.org/diseases-conditions/copd/basics/ diseases: Learn about ARDS. Retrieved from http://
treatment/con-20032017 www.lung.org/lung-health-and-diseases/lung-
disease-lookup/ards/learn-about-ards.html
16. R
osto, E. (Ed.). (2009). Pathophysiology Made
Incredibly Easy!. Lippincott Williams & Wilkins. 29. Leaver, S. K., & Evans, T. W. (2007). Acute
respiratory distress syndrome. British Medical
17. M
erck Manual (n.d.). Aspiration pneumonitis Journal, 7616, 389.
and pneumonia. Retrieved from http://www.
merckmanuals.com/professional/pulmonary- 30. National Institutes of Health. National Heart,
disorders/pneumonia/aspiration-pneumonitis- Lung and Blood Institute (n.d.). Diseases and
and-pneumonia Conditions Index. Acute Respiratory Distress
Syndrome (ARDS): What Is ARDS? Retrieved from
18. C
enter for Disease Control and Prevention (CDC). https://www.nhlbi.nih.gov/health/health-topics/
(n.d.). Pneumonia. Retrieved from http://www.cdc. topics/ards
gov/pneumonia/epic/overview.html
31. Pierrakos, C., Karanikolas, M., Scolletta, S.,
19. M
ayo Clinic (n.d.). Diseases and conditions: Karamouzos, V., & Velissaris, D. (2012). Acute
Pneumonia tests and diagnosis. Retrieved from respiratory distress syndrome: pathophysiology
http://www.mayoclinic.org/diseases-conditions/ and therapeutic options. Journal of clinical
pneumonia/basics/tests-diagnosis/con-20020032 medicine research, 4(1), 7-16.
20. A
merican Lung Association (n.d.). Diagnosing and 32. Ware, L. B., & Matthay, M. A. (2000). The acute
treating pneumonia. Retrieved from http://www. respiratory distress syndrome. New England Journal
lung.org/lung-health-and-diseases/lung-disease- of Medicine, 342(18), 1334-1349.
lookup/pneumonia/diagnosing-and-treating.html
33. Mayo Clinic (n.d.). Diseases and conditions: ARDS
21. C
ollard, H. R. Merck Manual (n.d.). Overview of symptoms. Retrieved from http://www.mayoclinic.
interstitial lung disease. Retrieved from http:// org/diseases-conditions/ards/basics/symptoms/
www.merckmanuals.com/home/lung-and-airway- con-20030070
disorders/interstitial-lung-diseases/overview-of-
interstitial-lung-diseases 34. National Institutes of Health. National Heart,
Lung and Blood Institute (n.d.). How is ARDS
22. C
hapman, J.T. (2010, August 10). Interstitial diagnosed? Retrieved from https://www.nhlbi.nih.
lung disease. Retrieved from http://www. gov/health/health-topics/topics/ards/diagnosis
clevelandclinicmeded.com/medicalpubs/
diseasemanagement/pulmonary/interstitial-lung- 35. Shelly, M. P., & Nightingale, P. (1999). ABC of
disease/ intensive care: respiratory support. BMJ: British
Medical Journal, 318(7199), 1674.
42. W
ebMD (n.d.). Lung disease and respiratory health 54. M
erck Manual (n.d.). Pleural effusion. Retrieved
center: Bronchoscopy. Retrieved from http://www. from http://www.merckmanuals.com/
webmd.com/lung/bronchoscopy-16978 professional/pulmonary-disorders/mediastinal-
and-pleural-disorders/pleural-effusion
43. A
merican Thoracic Society (n.d.). What are
corticosteroid (anti-inflammatory) medications? 55. L
ight, R. W. (n.d.). Merck Manual Professional
Retrieved from https://www.thoracic.org/copd- Version: Pneumothorax. Retrieved from http://www.
guidelines/for-patients/what-kind-of-medications- merckmanuals.com/professional/pulmonary-
are-there-for-copd/what-are-corticosteroid-anti- disorders/mediastinal-and-pleural-disorders/
inflammatory-medications.php pneumothorax
44. J ohn Hopkins Medicine (n.d.). Decannulation. 56. Lechtzin, N. (n.d.). Merck Manual Professional Ver-
Retrieved from http://www.hopkinsmedicine.org/ sion: Pulmonary function testing (PFT). Retrieved
tracheostomy/living/decannulation.html from http://www.merckmanuals.com/profession-
al/SearchResults?query=Pulmonary+Function+-
45. L
echtzin, N. (n.d.). Merck Manual Professional Testing++(PFT)&icd9=MM786%3bMM787
Version: Dyspnea. Retrieved from http://www.
merckmanuals.com/professional/pulmonary- 57. American Thoracic Society (n.d.). Patient
disorders/symptoms-of-pulmonary-disorders/ information series: Pulse oximetry. Retrieved from
dyspnea https://www.thoracic.org/patients/patient-
resources/resources/pulse-oximetry.pdf
46. M
erck Manual (n.d.). Bladder catheterization.
Retrieved from http://www.merckmanuals. 58. Cleveland Clinic (n.d.). Diseases and conditions:
com/professional/genitourinary-disorders/ Pursed lip breathing. Retrieved from http://
genitourinary-tests-and-procedures/bladder- my.clevelandclinic.org/health/diseases_
catheterization conditions/hic_Understanding_COPD/
hic_Pulmonary_Rehabilitation_Is_it_for_You/
hic_Pursed_Lip_Breathing
1. Lung injury associated with Acute Respiratory 5. A non-invasive means of measuring oxygen
Distress Syndrome (ARDS) is commonly saturation levels in the blood with a small
described as having three distinct but device that is usually attached to a fingertip, but
overlapping phases. The proliferation phase, can also be used on a toe or an ear: ________.
characterized by tissue damage and narrowing a. Positive end expiratory pressure (PEEP
of air space, is the ________ phase. b. Pulmonary function test (PFT)
a. Final c. Pulse oximetry
b. First d. Tracheostomy
c. Second
d. Third 6. Individuals blow into the mouthpiece of the
device and are encouraged to exhale normally
before inhaling slowly. An indicator within the
2. ________ can be further classified as hospital- chamber of the device will rise upon inhalation
acquired, community-acquired, or ventilator- providing an observable measure of volume
acquired. that may be recorded to assess progress.
a. Acute Respiratory Distress Syndrome (ARDS) a. Incentive spirometry (IS)
b. Chronic Obstructive Pulmonary Disease b. Non-invasive positive pressure ventilation
(COPD) (NIPPV)
c. Interstitial Lung Disease (ILD) c. Pulse oximetry
d. Pneumonia (PNA) d. Pursed-lip breathing
3. ________ is not a single disease but rather an 7. The most common form of ________ is the
umbrella term used to describe progressive lung beta-adrenergic agonist. It is most commonly
diseases that include emphysema and chronic inhaled so that it can work rapidly.
bronchitis. It is considered preventable, but it a. Bronchodilator
is also a progressive, life-threatening disorder b. Incentive spirometry
in which the lungs are irreparably damaged c. Mechanical ventilation
making it difficult to breathe. d. Oxidizer
a. Acute Respiratory Distress Syndrome (ARDS)
b. Chronic Obstructive Pulmonary Disease 8. The primary focus of OT in this setting is to
(COPD) promote strength, endurance, and mobility
c. Interstitial Lung Disease (ILD) within the context of ADL and IADL re-training,
d. Pneumonia (PNA) and provide client/caregiver education,
including energy conservation strategies, in
4. Regardless of etiology and type, the primary order to manage conditions at home and in the
clinical signs and symptoms of ________ are community upon discharge: ________.
similar, and include dyspnea and a non- a. Acute Care Hospitals
productive cough. Additional symptoms, such b. Home Care, including Independent and
as increased sputum production, hemoptysis Assisted Living Facilities
associated with microscopic hemorrhages, and c. Inpatient Rehab and Skilled Nursing Facilities
wheezing, as well as non respiratory related d. Long-term Acute Care
symptoms, such as myalgia and joint pain may
help to further classify the disease. 9. A 30-point questionnaire designed to measure
a. Acute Respiratory Distress Syndrome (ARDS) cognitive impairment, most commonly used
b. Chronic Obstructive Pulmonary Disease as a screen for dementia but can be used to
(COPD) estimate cognitive impairment associated with
c. Interstitial Lung Disease (ILD) illness or injury: ________.
d. Pneumonia (PNA) a. Borg Rating of Perceived Exertion Scale (RPE)
b. Functional Capacity Evaluation (FCE)
c. Short Portable Mental Status Questionnaire test
(SPMSQ)
d. The Mini Mental State Examination (MMSE)
NCBOT #:_______________________________________________________________________________________________
By submitting this final exam for grading, I hereby certify that I have spent the required time to study
this course material and that I have personally completed each module/session of instruction.
1. A B C D 5. A B C D 9. A B C D 13. A B C D 17. A B C D
2. A B C D 6. A B C D 10. A B C D 14. A B C D 18. A B C D
3. A B C D 7. A B C D 11. A B C D 15. A B C D 19. A B C D
4. A B C D 8. A B C D 12. A B C D 16. A B C D 20. A B C D
COURSE EVALUATION
Learner Name:_____________________________________________ Completion Date: ______________________________
Disagree Agree
Orientation was thorough and clear 1 2 3 4 5
Instructional personnel disclosures were readily
available and clearly stated 1 2 3 4 5
Learning objectives were clearly stated 1 2 3 4 5
Completion requirements were clearly stated 1 2 3 4 5
Content was well-organized 1 2 3 4 5
Content was informative 1 2 3 4 5
Content reflected stated learning objectives 1 2 3 4 5
Exam assessed stated learning objectives 1 2 3 4 5
Exam was graded promptly 1 2 3 4 5
Satisfied with learning experience 1 2 3 4 5
Satisfied with customer service (if applicable) 1 2 3 4 5 n/a
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________